Pune, Jan. 10, 2023 (GLOBE NEWSWIRE) -- "Drug Repurposing Market" research report focus on overall information that can help to take decisions on current market situation.
Drug Repurposing Market Report Contains: -
- Complete overview of the global Drug Repurposing Market
- Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned.
- Top Country data and analysis for United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Drug Repurposing markets such as North America, Europe, Asia-Pacific, South America and Middle East and Africa
- Description and analysis of Drug Repurposing market potential by type, Deep Dive, disruption, application capacity, end use industry
- impact evaluation of most important drivers and restraints, and dynamics of the global Drug Repurposing market and current trends in the enterprise
- Detailed profiles of the Top major players in the industry, including. Astellas Pharma,Biovista,Novartis,AbbVie,Pfizer,Allergan,NuMedii
Get a Sample Copy of the Report at – https://proficientmarketinsights.com/enquiry/request-sample/21342769
National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.
The global Drug Repurposing market size is projected to reach US$ 30920 million by 2028, from US$ 24570 million in 2021, at a CAGR of 2.9% during 2022-2028.
Requirement of low investment of time and money in the drug development is the prime advantage of drug repurposing and majority of the drugs in pipeline of major pharmaceutical companies are thus adopt this method. Some of the factors accelerating the drug repurposing activities include sunk research cost, ready availably of bioavailability, pharmacology, toxicity profile & pharmacokinetics data, well established manufacturing protocol etc.; which are expected to drive the global drug repurposing market.
Inquire or Share Your Questions If Any Before the Purchasing This Report – https://proficientmarketinsights.com/enquiry/pre-order-enquiry/21342769
There are thousands of failed molecules shelved into the drug libraries, which hold vast potential to reposition. Whereas, limited access chemical structure data of drug molecules, lack of funding etc. are some of the factors limiting the growth of global drug repurposing market.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drug Repurposing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drug Repurposing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drug Repurposing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drug Repurposing market.
Global Drug Repurposing Scope and Market Size
Drug Repurposing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Drug Repurposing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Drug Repurposing Market segments help decision-makers direct the product, sales, and marketing strategies, and can power your product development cycles by informing how you make product offerings for different segments.
Segment by Type
- Oncology
- CNS Diseases
- Neurodegenerative Diseases
- Others
Segment by Application
- Hospitals
- Ambulatory Surgical Centers
- Others
Market segment by Region/Country including: -
- North America (United States, Canada, and Mexico)
- Europe (Germany, UK, France, Italy, Russia and Spain, etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia, Southeast Asia, etc.)
- South America (Brazil, Argentina, Colombia, etc.)
- Middle East & Africa (South Africa, UAE, Saudi Arabia, etc.)
Key Players in the Drug Repurposing Market: -
- Astellas Pharma
- Biovista
- Novartis
- AbbVie
- Pfizer
- Allergan
- NuMedii
Get a Sample Copy of the Report at - https://proficientmarketinsights.com/enquiry/request-sample/21342769
Key Benefits of Drug Repurposing Market Research Report:
- Types, applications, regions, and key players covered in the study
- Industry drivers, restraints, and opportunities covered in the study
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Artificial Intelligence AI Chips Market
- Sales, price, revenue, market share, and growth rate are covered in the report sales channels, distributors, traders, dealers, etc. are covered in the report
Detailed TOC of Global Drug Repurposing Market Research Report 2022
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Repurposing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Oncology
1.2.3 CNS Diseases
1.2.4 Neurodegenerative Diseases
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drug Repurposing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drug Repurposing Market Perspective (2017-2028)
2.2 Drug Repurposing Growth Trends by Region
2.2.1 Drug Repurposing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Drug Repurposing Historic Market Size by Region (2017-2022)
2.2.3 Drug Repurposing Forecasted Market Size by Region (2023-2028)
2.3 Drug Repurposing Market Dynamics
2.3.1 Drug Repurposing Industry Trends
2.3.2 Drug Repurposing Market Drivers
2.3.3 Drug Repurposing Market Challenges
2.3.4 Drug Repurposing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Repurposing Players by Revenue
3.1.1 Global Top Drug Repurposing Players by Revenue (2017-2022)
3.1.2 Global Drug Repurposing Revenue Market Share by Players (2017-2022)
3.2 Global Drug Repurposing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Repurposing Revenue
3.4 Global Drug Repurposing Market Concentration Ratio
3.4.1 Global Drug Repurposing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Repurposing Revenue in 2021
3.5 Drug Repurposing Key Players Head office and Area Served
3.6 Key Players Drug Repurposing Product Solution and Service
3.7 Date of Enter into Drug Repurposing Market
3.8 Mergers & Acquisitions, Expansion Plans
Get a Sample Copy of the Report at - https://proficientmarketinsights.com/enquiry/request-sample/21342769
1.To study and analyze the global Drug Repurposing consumption (value) by key regions/countries, product type and application
2.To understand the structure of Drug Repurposing market by identifying its various sub segments.
3.Focuses on the key global Drug Repurposing manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Drug Repurposing with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Drug Repurposing submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global Drug Repurposing market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the Drug Repurposing market and its impact in the global market.
Learn about the Drug Repurposing market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the Drug Repurposing market.
Besides the standard structure reports, we also provide custom research according to specific requirements
Purchase this Report (Price 2900 USD for a Single-User License) – https://proficientmarketinsights.com/purchase/21342769
About Proficient market insights:
Proficient market insights is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.
Web: https://proficientmarketinsights.com/
